{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:22:43Z","timestamp":1784031763639,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00880"],"award-info":[{"award-number":["PI20\/00880"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00900"],"award-info":[{"award-number":["PI14\/00900"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01307"],"award-info":[{"award-number":["PI17\/01307"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012513","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Cardiovasculares","doi-asserted-by":"publisher","award":["CB\/11\/00222"],"award-info":[{"award-number":["CB\/11\/00222"]}],"id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","award":["2019AEP148"],"award-info":[{"award-number":["2019AEP148"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-104366RB-C21"],"award-info":[{"award-number":["PID2019-104366RB-C21"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Novel developmental mutations associated with disease are a continuous challenge in medicine. Clinical consequences caused by these mutations include neuron and cognitive alterations that can lead to epilepsy or autism spectrum disorders. Often, it is difficult to identify the physiological defects and the appropriate treatments.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We have isolated and cultured primary cells from the skin of a patient with combined epilepsy and autism syndrome. A mutation in the potassium channel protein Kv10.2 was identified. We have characterised the alteration of the mutant channel and found that it causes loss of function (LOF). Primary cells from the skin displayed a very striking growth defect and increased differentiation. In vitro treatment with various carbonic anhydrase inhibitors with various degrees of specificity for potassium channels, (Brinzolamide, Acetazolamide, Retigabine) restored the activation capacity of the mutated channel. Interestingly, the drugs also recovered in vitro the expansion capacity of the mutated skin cells. Furthermore, treatment with Acetazolamide clearly improved the patient regarding epilepsy and cognitive skills. When the treatment was temporarily halted the syndrome worsened again.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>By in vitro studying primary cells from the patient and the activation capacity of the mutated protein, we could first, find a readout for the cellular defects and second, test pharmaceutical treatments that proved to be beneficial. The results show the involvement of a novel LOF mutation of a Potassium channel in autism syndrome with epilepsy and the great potential of in vitro cultures of primary cells in personalised medicine of rare diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02499-z","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T06:02:43Z","timestamp":1662444163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A novel loss-of-function mutation of the voltage-gated potassium channel Kv10.2 involved in epilepsy and autism"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9105-2401","authenticated-orcid":false,"given":"Jes\u00fas","family":"Gal\u00e1n-Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7097-1708","authenticated-orcid":false,"given":"Paula G.","family":"Socu\u00e9llamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Baena-Nuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizbeth","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0930-0021","authenticated-orcid":false,"given":"Teresa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda S.","family":"P\u00e9rez-Poyato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-1960","authenticated-orcid":false,"given":"Carmen","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7578-241X","authenticated-orcid":false,"given":"Domingo","family":"Gonz\u00e1lez-Lamu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-4542","authenticated-orcid":false,"given":"Alberto","family":"Gandarillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"2499_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-publhealth-031816-044318","volume":"38","author":"K Lyall","year":"2017","unstructured":"Lyall K, Croen L, Daniels J, Fallin MD, Ladd-Acosta C, Lee BK, Park BY, Snyder NW, Schendel D, Volk H, Windham GC, Newschaffer C. The changing epidemiology of autism spectrum disorders. Annu Rev Public Health. 2017;38:81\u2013102.","journal-title":"Annu Rev Public Health"},{"key":"2499_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.05.007","volume":"190","author":"SR Sharma","year":"2018","unstructured":"Sharma SR, Gonda X, Tarazi FI. Autism spectrum disorder: classification, diagnosis and therapy. Pharmacol Ther. 2018;190:91\u2013104.","journal-title":"Pharmacol Ther"},{"key":"2499_CR3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1056\/NEJMra022308","volume":"13","author":"BS Chang","year":"2003","unstructured":"Chang BS, Lowenstein DH. Mechanisms of disease Epilepsy. N Engl J Med. 2003;13:1257\u201366.","journal-title":"N Engl J Med"},{"key":"2499_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.yebeh.2015.03.017","volume":"47","author":"BH Lee","year":"2015","unstructured":"Lee BH, Smith T, Paciorkowski AR. Autism spectrum disorder and epilepsy: disorders with a shared biology. Epilepsy Behav. 2015;47:191\u2013201.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"2499_CR5","doi-asserted-by":"publisher","first-page":"a022749","DOI":"10.1101\/cshperspect.a022749","volume":"6","author":"AW Buckley","year":"2016","unstructured":"Buckley AW, Holmes GL. Epilepsy and autism. Cold Spring Harbor Perspect Med. 2016;6(4):a022749.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"2499_CR6","first-page":"1","volume":"57","author":"J Kim","year":"2014","unstructured":"Kim J. Channelopathies. 2014;57(1):1\u201318.","journal-title":"Channelopathies"},{"issue":"4","key":"2499_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10072-019-04190-x","volume":"41","author":"E Bartolini","year":"2020","unstructured":"Bartolini E, Campostrini R, Kiferle L, Pradella S, Rosati E, Chinthapalli K, Palumbo P. Epilepsy and brain channelopathies from infancy to adulthood. Neurol Sci. 2020;41(4):749\u201361.","journal-title":"Neurol Sci"},{"key":"2499_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2013.00222","volume":"4","author":"G Schmunk","year":"2013","unstructured":"Schmunk G, Gargus JJ. Channelopathy pathogenesis in autism spectrum disorders. Front Genet. 2013;4:1\u201320.","journal-title":"Front Genet"},{"key":"2499_CR9","first-page":"1","volume":"9","author":"G Luca","year":"2015","unstructured":"Luca G, Ilenio S, Martino C, Luigi C, Fabio F, Maria CD, Mauro P. Update on the implication of potassium channels in autism: K+ channelautism spectrum disorder. Front Cell Neurosci. 2015;9:1\u201314.","journal-title":"Front Cell Neurosci"},{"issue":"24","key":"2499_CR10","doi-asserted-by":"publisher","first-page":"10789","DOI":"10.1523\/JNEUROSCI.19-24-10789.1999","volume":"19","author":"MJ Saganich","year":"1999","unstructured":"Saganich MJ, Vega-Saenz De Miera E, Nadal MS, Baker H, Coetzee WA, Rudy B. Cloning of components of a novel subthreshold-activating K+ channel with a unique pattern of expression in the cerebral cortex. J Neurosci. 1999;19(24):10789\u2013802.","journal-title":"J Neurosci"},{"issue":"3","key":"2499_CR11","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/cphy.c110047","volume":"2","author":"C Gonz\u00e1lez","year":"2012","unstructured":"Gonz\u00e1lez C, Baez-Nieto D, Valencia I, Oyarz\u00fan I, Rojas P, Naranjo D, Latorre R. K+ channels: function-structural overview. Compr Physiol. 2012;2(3):2087\u2013149.","journal-title":"Compr Physiol"},{"issue":"1\u20133","key":"2499_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0014-5793(02)03055-7","volume":"524","author":"M Ju","year":"2002","unstructured":"Ju M, Wray D. Molecular identification and characterisation of the human eag2 potassium channel. FEBS Lett. 2002;524(1\u20133):204\u201310.","journal-title":"FEBS Lett"},{"issue":"16","key":"2499_CR13","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1101\/gad.193789.112","volume":"26","author":"X Huang","year":"2012","unstructured":"Huang X, Dubuc AM, Hashizume R, Berg J, He Y, Wang J, Chiang C, Cooper MK, Northcott PA, Taylor MD, Barnes MJ, Tihan T, Chen J, Hackett CS, Weiss WA, David James C, Rowitch DH, Shuman MA, Jan YN, Jan LY. Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics. Genes Dev. 2012;26(16):1780\u201396.","journal-title":"Genes Dev"},{"issue":"1","key":"2499_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2005.02.016","volume":"233","author":"J Camacho","year":"2006","unstructured":"Camacho J. Ether \u00e0 go-go potassium channels and cancer. Cancer Lett. 2006;233(1):1\u20139.","journal-title":"Cancer Lett"},{"issue":"12","key":"2499_CR15","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1016\/j.febslet.2006.03.062","volume":"580","author":"W St\u00fchmer","year":"2006","unstructured":"St\u00fchmer W, Alves F, Hartung F, Zientkowska M, Pardo LA. Potassium channels as tumour markers. FEBS Lett. 2006;580(12):2850\u20132.","journal-title":"FEBS Lett"},{"issue":"7","key":"2499_CR16","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/epi.12201","volume":"54","author":"KR Veeramah","year":"2013","unstructured":"Veeramah KR, Johnstone L, Karafet TM, Wolf D, Sprissler R, Salogiannis J, Barth-Maron A, Greenberg ME, Stuhlmann T, Weinert S, Jentsch TJ, Pazzi M, Restifo LL, Talwar D, Erickson RP, Hammer MF. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia. 2013;54(7):1270\u201381.","journal-title":"Epilepsia"},{"issue":"42","key":"2499_CR17","doi-asserted-by":"publisher","first-page":"16586","DOI":"10.1523\/JNEUROSCI.2307-13.2013","volume":"33","author":"Y Yang","year":"2013","unstructured":"Yang Y, Vasylyev D, Dib-Hajj F, Veeramah KR, Hammer MF, Dib-Hajj SD, Waxman SG. Multistate structural modeling and voltage-clamp analysis of epilepsy\/autism mutation Kv10.2-R327H demonstrate the role of this residue in stabilizing the channel closed state. J Neurosci. 2013;33(42):16586\u201393.","journal-title":"J Neurosci"},{"issue":"11","key":"2499_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrg3031","volume":"12","author":"MJ Bamshad","year":"2011","unstructured":"Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12(11):745\u201355.","journal-title":"Nat Rev Genet"},{"issue":"6","key":"2499_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng.835","volume":"43","author":"BJ O\u2019Roak","year":"2011","unstructured":"O\u2019Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, MacKenzie AP, Ng SB, Baker C, Rieder MJ, Nickerson DA, Bernier R, Fisher SE, Shendure J, Eichler EE. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet. 2011;43(6):585\u20139.","journal-title":"Nat Genet"},{"issue":"7526","key":"2499_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature13908","volume":"515","author":"I Iossifov","year":"2014","unstructured":"Iossifov I, O\u2019Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, Stessman HA, Witherspoon KT, Vives L, Patterson KE, Smith JD, Paeper B, Nickerson DA, Dea J, Dong S, Gonzalez LE, Mandell JD, Mane SM, Murtha MT, Sullivan CA, Walker MF, Waqar Z, Wei L, Willsey AJ, Yamrom B, Lee YH, Grabowska E, Dalkic E, Wang Z, Marks S, Andrews P, Leotta A, Kendall J, Hakker I, Rosenbaum J, Ma B, Rodgers L, Troge J, Narzisi G, Yoon S, Schatz MC, Ye K, McCombie WR, Shendure J, Eichler EE, State MW, Wigler M. The contribution of de novo coding mutations to autism spectrum disorder. Nature. 2014;515(7526):216\u201321.","journal-title":"Nature"},{"issue":"2","key":"2499_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1085\/jgp.201711898","volume":"150","author":"ZM James","year":"2018","unstructured":"James ZM, Zagotta WN. Structural insights into the mechanisms of CNBD channel function. J Gen Physiol. 2018;150(2):225\u201344.","journal-title":"J Gen Physiol"},{"issue":"1","key":"2499_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jmb.2012.06.025","volume":"423","author":"MJ Marques-Carvalho","year":"2012","unstructured":"Marques-Carvalho MJ, Sahoo N, Muskett FW, Vieira-Pires RS, Gabant G, Cadene M, Sch\u00f6nherr R, Morais-Cabral JH. Structural, biochemical, and functional characterization of the cyclic nucleotide binding homology domain from the mouse EAG1 potassium channel. J Mol Biol. 2012;423(1):34\u201346.","journal-title":"J Mol Biol"},{"key":"2499_CR23","doi-asserted-by":"publisher","first-page":"26355","DOI":"10.7554\/eLife.26355","volume":"6","author":"G Dai","year":"2017","unstructured":"Dai G, Zagotta WN. Molecular mechanism of voltage-dependent potentiation of KCNH potassium channels. Elife. 2017;6:26355.","journal-title":"Elife"},{"issue":"3","key":"2499_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0092-8674(75)90183-X","volume":"6","author":"JG Rheinwald","year":"1975","unstructured":"Rheinwald JG, Green H. Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell. 1975;6(3):317\u201330.","journal-title":"Cell"},{"issue":"4","key":"2499_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/0092-8674(93)90251-K","volume":"73","author":"PH Jones","year":"1993","unstructured":"Jones PH, Watt FM. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell. 1993;73(4):713\u201324.","journal-title":"Cell"},{"issue":"3","key":"2499_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1083\/jcb.90.3.732","volume":"90","author":"S Banks-Schlegel","year":"1981","unstructured":"Banks-Schlegel S, Green H. Involucrin synthesis and tissue assembly by keratinocytes in natural and cultured human epithelia. J Cell Biol. 1981;90(3):732\u20137.","journal-title":"J Cell Biol"},{"key":"2499_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112923","volume":"209","author":"S Kumar","year":"2021","unstructured":"Kumar S, Rulhania S, Jaswal S, Monga V. Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. Eur J Med Chem. 2021;209: 112923.","journal-title":"Eur J Med Chem"},{"issue":"8","key":"2499_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2146\/ajhp170279","volume":"75","author":"MA van Berkel","year":"2018","unstructured":"van Berkel MA, Elefritz JL. Evaluating off-label uses of acetazolamide. Am J Health Syst Pharm. 2018;75(8):524\u201331.","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"2499_CR29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1177\/106002809603000515","volume":"30","author":"WG Reiss","year":"1996","unstructured":"Reiss WG, Oles KS. Acetazolamide in the treatment of seizures. Ann Pharmacother. 1996;30(5):514\u20138.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"2499_CR30","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ana.25457","volume":"85","author":"AF Mart\u00ednez-Monseny","year":"2019","unstructured":"Mart\u00ednez-Monseny AF, Bolasell M, Callej\u00f3n-P\u00f3o L, Cuadras D, Freniche V, Itzep DC, Gassiot S, Arango P, Casas-Alba D, de la Morena E, Corral J, Montero R, P\u00e9rez-Cerd\u00e1 C, P\u00e9rez B, Artuch R, Jaeken J, Serrano M, Vel\u00e1zquez-Fragua R, Garc\u00eda O, Gutierrez-Solana LG, Macaya A, P\u00e9rez-Due\u00f1as B, Aguilera-Albesa S, L\u00f3pez L, Miranda MC, Carratala F, Yoldi ME, L\u00f3pez-Laso E, Sierra-C\u00f3rcoles MC, Sebasti\u00e1n-Garc\u00eda I, A\u00edsa E, Cancho-Candela R, Carrasco-Marina ML, Couce ML, Rold\u00e1n S, Muchart J, Morales M, Conde-Lorenzo N. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG). Ann Neurol. 2019;85(5):740\u201351.","journal-title":"Ann Neurol"},{"issue":"11","key":"2499_CR31","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ejhf.1478","volume":"21","author":"FH Verbrugge","year":"2019","unstructured":"Verbrugge FH, Martens P, Ameloot K, Haemels V, Penders J, Dupont M, Tang WHW, Droogn\u00e9 W, Mullens W. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail. 2019;21(11):1415\u201322.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"2499_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/17425255.2020.1743679","volume":"16","author":"CT Supuran","year":"2020","unstructured":"Supuran CT. An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol. 2020;16(4):297\u2013307.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"22","key":"2499_CR33","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.1016\/j.bmc.2013.08.033","volume":"21","author":"MA Pinard","year":"2013","unstructured":"Pinard MA, Boone CD, Rife BD, Supuran CT, McKenna R. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases. Bioorg Med Chem. 2013;21(22):7210\u20135.","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"2499_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1528-1167.2011.03365.x","volume":"53","author":"MJ Gunthorpe","year":"2012","unstructured":"Gunthorpe MJ, Large CH, Sankar R. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy. Epilepsia. 2012;53(3):412\u201324.","journal-title":"Epilepsia"},{"issue":"2","key":"2499_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/mol.58.2.253","volume":"58","author":"MJ Main","year":"2000","unstructured":"Main MJ, Cryan JE, Dupere JRB, Cox B, Clare JJ, Burbidge SA. Modulation of KCNQ2\/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol. 2000;58(2):253\u201362.","journal-title":"Mol Pharmacol"},{"issue":"3","key":"2499_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1124\/mol.58.3.591","volume":"58","author":"AD Wickenden","year":"2000","unstructured":"Wickenden AD, Yu W, Zou A, Jegla T, Wagoner PK. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2\/Q3 potassium channels. Mol Pharmacol. 2000;58(3):591\u2013600.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"2499_CR37","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1124\/mol.61.4.921","volume":"61","author":"JF Otto","year":"2002","unstructured":"Otto JF, Kimball MM, Wilcox KS. Effects of the anticonvulsant retigabine on cultured cortical neurons: Changes in electroresponsive properties and synaptic transmission. Mol Pharmacol. 2002;61(4):921\u20137.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"2499_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41388-020-01520-8","volume":"40","author":"I de Pedro","year":"2021","unstructured":"de Pedro I, Gal\u00e1n-Vidal J, Freije A, de Diego E, Gandarillas A. p21CIP1 controls the squamous differentiation response to replication stress. Oncogene. 2021;40(1):152\u201362.","journal-title":"Oncogene"},{"key":"2499_CR39","doi-asserted-by":"crossref","unstructured":"Bliss SL. Test Reviews: Newborg, J. (2005). Battelle Developmental Inventory\u2212Second Edition. Itasca, IL: Riverside. Journal of Psychoeducational Assessment. 2007. p. 409\u201315.","DOI":"10.1177\/0734282907300382"},{"issue":"4","key":"2499_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3109\/17518421003736032","volume":"13","author":"JL Matson","year":"2010","unstructured":"Matson JL, Hess JA, Sipes M, Horovitz M. Developmental profiles from the Battelle developmental inventory: a comparison of toddlers diagnosed with Down Syndrome, global developmental delay and premature birth. Dev Neurorehabil. 2010;13(4):234\u20138.","journal-title":"Dev Neurorehabil"},{"issue":"1","key":"2499_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/17518423.2013.839585","volume":"17","author":"RL Goldin","year":"2014","unstructured":"Goldin RL, Matson JL, Beighley JS, Jang J. Autism spectrum disorder severity as a predictor of Battelle Developmental Inventory-Second Edition (BDI-2) scores in toddlers. Dev Neurorehabil. 2014;17(1):39\u201343.","journal-title":"Dev Neurorehabil"},{"issue":"12","key":"2499_CR42","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1007\/s11064-020-03143-7","volume":"45","author":"Y Liu","year":"2020","unstructured":"Liu Y, Tang Y, Yan J, Du D, Yang Y, Chen F. Deletion of Kv10.2 causes abnormal dendritic arborization and epilepsy susceptibility. Neurochem Res. 2020;45(12):2949\u201358.","journal-title":"Neurochem Res"},{"issue":"3","key":"2499_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/aur.186","volume":"4","author":"AJ Griswold","year":"2011","unstructured":"Griswold AJ, Ma D, Sacharow SJ, Robinson JL, Jaworski JM, Wright HH, Abramson RK, Lyb\u00e6k H, \u00d8yen N, Cuccaro ML, Gilbert JR, Pericak-Vance MA. A de novo 1.5Mb microdeletion on chromosome 14q23.2\u201323.3 in a patient with autism and spherocytosis. Autism Res. 2011;4(3):221\u20137.","journal-title":"Autism Res"},{"issue":"6","key":"2499_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1399-0004.2008.01072.x","volume":"74","author":"H Lyb\u00e6k","year":"2008","unstructured":"Lyb\u00e6k H, \u00d8yen N, Fauske L, Houge G. A 2.1 Mb deletion adjacent but distal to a 14q21q23 paracentric inversion in a family with spherocytosis and severe learning difficulties. Clin Genet. 2008;74(6):553\u20139.","journal-title":"Clin Genet"},{"key":"2499_CR45","unstructured":"Imbrigiotta N, Lenzo P, Bonsignore M. A Case of deletion of chromosome 14q23.3."},{"issue":"20","key":"2499_CR46","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1206524","volume":"367","author":"J de Ligt","year":"2012","unstructured":"de Ligt J, Willemsen MH, van Bon BWM, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BBA, Brunner HG, Veltman JA, Vissers LELM. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367(20):1921\u20139.","journal-title":"N Engl J Med"},{"issue":"9","key":"2499_CR47","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/WNR.0000000000001244","volume":"30","author":"M Li","year":"2019","unstructured":"Li M, Wang J, Liu Y, Wu J, Li F, Feng S, Du D, Chen F. Central changes in the Kv10.2 potassium channel in stress-induced hypertension rats. NeuroReport. 2019;30(9):637\u201344.","journal-title":"NeuroReport"},{"issue":"12","key":"2499_CR48","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s11064-019-02903-4","volume":"44","author":"J Wang","year":"2019","unstructured":"Wang J, Feng S, Li M, Liu Y, Yan J, Tang Y, Du D, Chen F. Increased expression of Kv10.2 in the hippocampus attenuates valproic acid-induced autism-like behaviors in rats. Neurochem Res. 2019;44(12):2796\u2013808.","journal-title":"Neurochem Res"},{"issue":"4","key":"2499_CR49","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/1073858418763752","volume":"24","author":"Z Niday","year":"2018","unstructured":"Niday Z, Tzingounis A. Potassium channel gain of function in epilepsy: an unresolved paradox. Neuroscientist. 2018;24(4):368\u201380.","journal-title":"Neuroscientist"},{"issue":"7130","key":"2499_CR50","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature05659","volume":"445","author":"E Fuchs","year":"2007","unstructured":"Fuchs E. Scratching the surface of skin development. Nature. 2007;445(7130):834\u201342.","journal-title":"Nature"},{"issue":"24","key":"2499_CR51","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.4161\/cc.22529","volume":"11","author":"A Gandarillas","year":"2012","unstructured":"Gandarillas A. The mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint. Cell Cycle. 2012;11(24):4507\u201316.","journal-title":"Cell Cycle"},{"issue":"7","key":"2499_CR52","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/sj.embor.7400449","volume":"6","author":"I Lauritzen","year":"2005","unstructured":"Lauritzen I, Chemin J, Honor\u00e9 E, Jodar M, Guy N, Lazdunski M, et al. Cross-talk between the mechano-gated K2P channel TREK-1 and the actin cytoskeleton. EMBO Rep. 2005;6(7):642\u20138.","journal-title":"EMBO Rep"},{"key":"2499_CR53","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.bbamem.2013.07.015","volume":"1838","author":"B Martinac","year":"2014","unstructured":"Martinac B. The ion channels to cytoskeleton connection as potential mechanism of mechanosensitivity. Biochim Biophys Acta Biomembranes. 2014;1838:682\u201391.","journal-title":"Biochim Biophys Acta Biomembranes."},{"issue":"1","key":"2499_CR54","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41598-018-36859-2","volume":"9","author":"P Mollinedo","year":"2019","unstructured":"Mollinedo P, Kapitansky O, Gonzalez-Lamuno D, Zaslavsky A, Real P, Gozes I, Gandarillas A, Fernandez-Luna JL. Cellular and animal models of skin alterations in the autism-related ADNP syndrome. Sci Rep. 2019;9(1):736.","journal-title":"Sci Rep"},{"issue":"4","key":"2499_CR55","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1681\/ASN.V641134","volume":"6","author":"M Allon","year":"1995","unstructured":"Allon M, Am J. Hyperkalemia in End-Stage and Management1\u20192. J Am Soc Nephrol. 1995;6(4):1134\u201342.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2499_CR56","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1053\/j.ajkd.2005.02.016","volume":"45","author":"KM Sowinski","year":"2005","unstructured":"Sowinski KM, Cronin D, Mueller BA, Kraus MA. Subcutaneous terbutaline use in CKD to reduce potassium concentrations. Am J Kidney Dis. 2005;45(6):1040\u20135.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2499_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ki.1989.1","volume":"35","author":"T Clausen","year":"1989","unstructured":"Clausen T, Everts ME. Regulation of the Na, K-pump in skeletal muscle. Kidney Int. 1989;35(1):1\u201313.","journal-title":"Kidney Int"},{"issue":"4","key":"2499_CR58","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/ajpcell.00096.2002","volume":"283","author":"AR Gosmanov","year":"2002","unstructured":"Gosmanov AR, Wong JA, Thomason DB. Duality of G protein-coupled mechanisms for \u03b2-adrenergic activation of NKCC activity in skeletal muscle. Am J Physiol Cell Physiol. 2002;283(4):1025\u201332.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"2499_CR59","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ygeno.2019.07.011","volume":"112","author":"I Roca","year":"2020","unstructured":"Roca I, Gonz\u00e1lez-Castro L, Maynou J, Palacios L, Fern\u00e1ndez H, Couce ML, Fern\u00e1ndez-Marmiesse A. PattRec: an easy-to-use CNV detection tool optimized for targeted NGS assays with diagnostic purposes. Genomics. 2020;112(2):1245\u201356.","journal-title":"Genomics"},{"key":"2499_CR60","doi-asserted-by":"crossref","unstructured":"Huber CD, Kim Id BY, Lohmueller Id KE. Population genetic models of GERP scores suggest pervasive turnover of constrained sites across mammalian evolution. 2020.","DOI":"10.1101\/836858"},{"issue":"3","key":"2499_CR61","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310\u20135.","journal-title":"Nat Genet"},{"issue":"4","key":"2499_CR62","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139.","journal-title":"Nat Methods"},{"issue":"4","key":"2499_CR63","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D, Cannon-Albright LA, Teerlink CC, Stanford JL, Isaacs WB, Xu J, Cooney KA, Lange EM, Schleutker J, Carpten JD, Powell IJ, Cussenot O, Cancel-Tassin G, Giles GG, MacInnis RJ, Maier C, Hsieh CL, Wiklund F, Catalona WJ, Foulkes WD, Mandal D, Eeles RA, Kote-Jarai Z, Bustamante CD, Schaid DJ, Hastie T, Ostrander EA, Bailey-Wilson JE, Radivojac P, Thibodeau SN, Whittemore AS, Sieh W. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99(4):877\u201385.","journal-title":"Am J Hum Genet"},{"key":"2499_CR64","doi-asserted-by":"crossref","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(Database issue).","DOI":"10.1093\/nar\/gkt1113"},{"key":"2499_CR65","first-page":"81","volume-title":"Cell growth and division","author":"JG Rheinwald","year":"1989","unstructured":"Rheinwald JG. Methods for clonal growth and serial cultivation of normal human epidermal keratinocytes and mesothelial cells. In: Baserga R, editor. Cell growth and division. Oxford: IRL Press; 1989. p. 81\u201394."},{"issue":"21","key":"2499_CR66","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1101\/gad.11.21.2869","volume":"11","author":"A Gandarillas","year":"1997","unstructured":"Gandarillas A, Watt FM. c-Myc promotes differentiation of human epidermal stem cells. Genes Dev. 1997;11(21):2869\u201382.","journal-title":"Genes Dev"},{"issue":"4","key":"2499_CR67","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/cvr\/cvv196","volume":"107","author":"C Moreno","year":"2015","unstructured":"Moreno C, Oliveras A, de La Cruz A, Bartolucci C, Mu\u00f1oz C, Salar E, Gimeno JR, Severi S, Comes N, Felipe A, Gonz\u00e1lez T, Lambiase P, Valenzuela C. A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome. Cardiovasc Res. 2015;107(4):613\u201323.","journal-title":"Cardiovasc Res"},{"issue":"110","key":"2499_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.yjmcc.2017.07.009","volume":"2017","author":"C Moreno","year":"2017","unstructured":"Moreno C, Oliveras A, Bartolucci C, Mu\u00f1oz C, de la Cruz A, Peraza DA, Gimeno JR, Mart\u00edn-Mart\u00ednez M, Severi S, Felipe A, Lambiase PD, Gonzalez T, Valenzuela C. D242N, a KV7.1 LQTS mutation uncovers a key residue for Iks voltaje-dependence. J Mol Cell Cardiol. 2017;2017(110):61\u20139.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"2499_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22031336","volume":"22","author":"A Macias","year":"2021","unstructured":"Macias A, de la Cruz A, Peraza DA, de Benito-Bueno A, Gonzalez T, Valenzuela C. K V 1.5-K V \u03b21.3 Recycling Is PKC-Dependent. Int J Mol Sci. 2021;22(3):1\u201312.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2499_CR70","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/sj.bjp.0704978","volume":"137","author":"T Gonz\u00e1lez","year":"2002","unstructured":"Gonz\u00e1lez T, Arias C, Caballero R, Moreno I, Delp\u00f3n E, Tamargo J, Valenzuela C. Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: Stereoselective bupivacaine block. Br J Pharmacol. 2002;137(8):1269\u201379.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2499_CR71","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.yjmcc.2007.11.004","volume":"44","author":"M Guizy","year":"2008","unstructured":"Guizy M, David M, Arias C, Zhang L, Cof\u00e1n M, Ruiz-Guti\u00e9rrez V, Ros E, Lillo MP, Martens JR, Valenzuela C. Modulation of the atrial specific Kv1.5 channel by the n-3 polyunsaturated fatty acid, \u03b1-linolenic acid. J Mol Cell Cardiol. 2008;44(2):323\u201335.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"2499_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-43677-7","volume":"9","author":"A Lopez-Hurtado","year":"2019","unstructured":"Lopez-Hurtado A, Peraza DA, Cercos P, Lagartera L, Gonzalez P, Dopazo XM, Herranz R, Gonzalez T, Martin-Martinez M, Mellstr\u00f6m B, Naranjo JR, Valenzuela C, Gutierrez-Rodriguez M. Targeting the neuronal calcium sensor DREAM with small-molecules for Huntington\u2019s disease treatment. Sci Rep. 2019;9(1):1\u201316.","journal-title":"Sci Rep"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02499-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02499-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02499-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:22:02Z","timestamp":1662452522000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02499-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2499"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02499-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research obtained approval by the ethical committee for Clinical Research and Studies in Cantabria, Spain (CEIC, Research Institute and Hospital Universitario Marqu\u00e9s de Valdecilla). The study is included in the research network RD16\/0022\/0010. We obtained informed consent from both parents for the skin biopsy, in vitro cultures and molecular studies (codes HUMV-651681831 and NM_129318.4) that are available in the clinical files of the patient at the Regional Health System.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Parents of the participant had given specific informed consent both to the study and its publication. Written informed consent for publication of the clinical details was obtained from the parents, and a copy of the consent form is available for review by the Editor of the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}